Bio-Thera Solutions, Ltd. (SHA:688177)
China flag China · Delayed Price · Currency is CNY
26.32
+0.02 (0.08%)
At close: May 30, 2025, 2:57 PM CST

Bio-Thera Solutions Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2016 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2019
Operating Revenue
787.98743.01704.41455.13836.58182.86
Upgrade
Other Revenue
0.150.150.380--
Upgrade
Revenue
788.13743.17704.79455.13836.58182.86
Upgrade
Revenue Growth (YoY)
10.78%5.44%54.85%-45.60%357.49%26023.37%
Upgrade
Cost of Revenue
228.6229.7194.67191.0935.919.92
Upgrade
Gross Profit
559.53513.46510.13264.04800.68162.95
Upgrade
Selling, General & Admin
282.8269.62201.3174.24215.45163.47
Upgrade
Research & Development
786.23777.63768.64616.39543.42562.65
Upgrade
Other Operating Expenses
7.855.024.913.342.171.59
Upgrade
Operating Expenses
1,0771,053975.04793.26761.93727.82
Upgrade
Operating Income
-517.62-539.04-464.91-529.2238.75-564.87
Upgrade
Interest Expense
-22.08-20.55-10.38-0.06-0.78-3.7
Upgrade
Interest & Investment Income
5.914.988.315.5321.6818.3
Upgrade
Currency Exchange Gain (Loss)
0.680.68-0.151.861.470.35
Upgrade
Other Non Operating Income (Expenses)
-0.23-0.25-0.33-0.26-0.39-0.47
Upgrade
EBT Excluding Unusual Items
-533.35-554.18-467.47-512.1560.74-550.39
Upgrade
Gain (Loss) on Sale of Investments
2.163.456.9714.5311.918.81
Upgrade
Gain (Loss) on Sale of Assets
-0.5-0.510.03-0.07-0.02-0.17
Upgrade
Asset Writedown
0.03-----0.13
Upgrade
Other Unusual Items
46.9740.9466.0517.2918.4218.67
Upgrade
Pretax Income
-484.68-510.3-394.42-480.491.04-513.23
Upgrade
Income Tax Expense
--0.1109.11-
Upgrade
Net Income
-484.68-510.3-394.53-480.481.94-513.23
Upgrade
Net Income to Common
-484.68-510.3-394.53-480.481.94-513.23
Upgrade
Shares Outstanding (Basic)
414415415414410404
Upgrade
Shares Outstanding (Diluted)
414415415414410404
Upgrade
Shares Change (YoY)
0.19%-0.10%0.28%1.09%1.38%16.97%
Upgrade
EPS (Basic)
-1.17-1.23-0.95-1.160.20-1.27
Upgrade
EPS (Diluted)
-1.17-1.23-0.95-1.160.20-1.27
Upgrade
Free Cash Flow
-26.33-182.5-723.01-671.64158.38-611.3
Upgrade
Free Cash Flow Per Share
-0.06-0.44-1.74-1.620.39-1.51
Upgrade
Gross Margin
70.99%69.09%72.38%58.01%95.71%89.11%
Upgrade
Operating Margin
-65.68%-72.53%-65.96%-116.28%4.63%-308.90%
Upgrade
Profit Margin
-61.50%-68.67%-55.98%-105.55%9.79%-280.66%
Upgrade
Free Cash Flow Margin
-3.34%-24.56%-102.58%-147.57%18.93%-334.30%
Upgrade
EBITDA
-431.98-454.21-383.34-448.35108.87-505.9
Upgrade
EBITDA Margin
-54.81%-61.12%-54.39%-98.51%13.01%-276.65%
Upgrade
D&A For EBITDA
85.6584.8381.5780.8870.1258.98
Upgrade
EBIT
-517.62-539.04-464.91-529.2238.75-564.87
Upgrade
EBIT Margin
-65.68%-72.53%-65.96%-116.28%4.63%-
Upgrade
Effective Tax Rate
----10.00%-
Upgrade
Revenue as Reported
788.13743.17704.79455.13836.58184.99
Upgrade
Advertising Expenses
-----7.77
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.